Intergenus cell fusion of prokaryotic bacteria was demonstrated for the first time; namely, fusion products doubly resistant to streptomycin and tetracycline were produced by polyethylene glycol treatment of a mixture of the streptomycin-resistant L-form of Pseudomonas aeruginosa and tetracycline-resistant L-form of Escherichia coli.